Telemedicine and the Prescribing of Controlled Substances After the End of The Covid-19 Pandemic Emergency: DEA Announces Two Significant Proposed Rules: Read the Summary Below, But Learn All the Details and More at HPM’s Webinar on March 23, 2023 (Details Forthcoming….)
FDA Law Blog
FEBRUARY 27, 2023
We will release exciting details of our upcoming webinar addressing telemedicine soon. And, as one who loves easy-to-follow charts… DEA has published one here , setting forth the various general parameters for prescribing via both telemedicine and in-person visits – and covering both the general and buprenorphine telemedicine proposed rules.
59 
Let's personalize your content